PETALING JAYA: Duopharma Biotech Bhd, which reported improved earnings in the second quarter, is optimistic about its outlook for the rest of year on higher public spending in the healthcare sector.
The drugmaker is also working to expand its niche product business.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!